Arch Venture Partners X, L.p. - Net Worth and Insider Trading

Over the past 18 months, Arch Venture Partners X, L.p. made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,100,000 shares made by Jonathan E Lim , a net purchase of 110,000 shares made by Alexander W. Casdin , and a net purchase of 10,000 shares made by Start Valerie Denise Harding .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 2,220,000 shares were bought by its insiders, resulting in a net purchase of 2,220,000 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, L.p. made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net sale of 949,000 shares made by Flagship Ventures Fund V, L.p. , a net purchase of 1,818,181 shares made by Arch Venture Fund X Overage, L.p. , and a net purchase of 1,818,181 shares made by Keith Crandell .

In summary, during the past 3 months, insiders sold 300,000 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 300,000 shares. During the past 18 months, 1,349,000 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,105,543 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, L.p. made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, L.p. made no insider transaction in Prime Medicine Inc (PRME). Other recent insider transactions involving Prime Medicine Inc (PRME) include a net sale of 886,157 shares made by Gv 2019 Gp, L.l.c. , a net purchase of 3,200,000 shares made by Robert Nelsen , and a net purchase of 3,200,000 shares made by Arch Venture Partners X, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Prime Medicine Inc (PRME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 886,157 shares of Prime Medicine Inc (PRME) were sold and 9,600,000 shares were bought by its insiders, resulting in a net purchase of 8,713,843 shares.

Prime Medicine Inc (PRME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, L.p. made no insider transaction in Neumora Therapeutics Inc (NMRA). Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 2,007,064 shares made by Kristina Burow , a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , and a net sale of 88,235 shares made by Robert A. Lenz .

In summary, during the past 3 months, insiders sold 210,023 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 210,023 shares. During the past 18 months, 210,023 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,083,810 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.